These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8584475)

  • 1. Conformational analysis of methylphenidate and its structural relationship to other dopamine reuptake blockers such as CFT.
    Froimowitz M; Patrick KS; Cody V
    Pharm Res; 1995 Oct; 12(10):1430-4. PubMed ID: 8584475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo and (±)-erythro diastereomers.
    McLaughlin G; Morris N; Kavanagh PV; Power JD; Dowling G; Twamley B; O'Brien J; Hessman G; Murphy B; Walther D; Partilla JS; Baumann MH; Brandt SD
    Drug Test Anal; 2017 Mar; 9(3):347-357. PubMed ID: 28103426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system.
    Heal DJ; Pierce DM
    CNS Drugs; 2006; 20(9):713-38. PubMed ID: 16953648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational analysis and a crystal structure of bupropion, an antidepressant with dopamine reuptake blocking activity.
    Froimowitz M; George C
    J Chem Inf Comput Sci; 1998; 38(3):506-10. PubMed ID: 9611786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of the enantiomers of threo-methylphenidate.
    Patrick KS; Caldwell RW; Ferris RM; Breese GR
    J Pharmacol Exp Ther; 1987 Apr; 241(1):152-8. PubMed ID: 3572779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational preferences of the potent dopamine reuptake blocker BTCP and its analogs and their incorporation into a pharmacophore model.
    Froimowitz M; Wu KM; Rodrigo J; George C
    J Comput Aided Mol Des; 2000 Feb; 14(2):135-46. PubMed ID: 10721502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro.
    Bartl J; Palazzesi F; Parrinello M; Hommers L; Riederer P; Walitza S; Grünblatt E
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):281-288. PubMed ID: 28690202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.
    Froimowitz M; Wu KM; Moussa A; Haidar RM; Jurayj J; George C; Gardner EL
    J Med Chem; 2000 Dec; 43(26):4981-92. PubMed ID: 11150168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and structural analysis of (±)-threo-ritalinic acid.
    Wyss S; Werner IA; Schweizer WB; Ametamey SM; Milicevic Sephton S
    Acta Crystallogr C; 2013 Nov; 69(Pt 11):1225-8. PubMed ID: 24192163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis of methylphenidate: comparison of molecular orbital and molecular mechanics methods.
    Gilbert KM; Skawinski WJ; Misra M; Paris KA; Naik NH; Buono RA; Deutsch HM; Venanzi CA
    J Comput Aided Mol Des; 2004 Nov; 18(11):719-38. PubMed ID: 15865064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the optical purity and absolute configuration of threo-methylphenidate by proton nuclear magnetic resonance spectroscopy with chiral solvating agent.
    Hanna GM; Lau-Cam CA
    J Pharm Biomed Anal; 1993 Aug; 11(8):665-70. PubMed ID: 8257731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton.
    Kozikowski AP; Araldi GL; Boja J; Meil WM; Johnson KM; Flippen-Anderson JL; George C; Saiah E
    J Med Chem; 1998 May; 41(11):1962-9. PubMed ID: 9599245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration.
    Ding YS; Gatley SJ; Thanos PK; Shea C; Garza V; Xu Y; Carter P; King P; Warner D; Taintor NB; Park DJ; Pyatt B; Fowler JS; Volkow ND
    Synapse; 2004 Sep; 53(3):168-75. PubMed ID: 15236349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and L-threo-methylphenidate in the human and baboon brain.
    Ding YS; Fowler JS; Volkow ND; Dewey SL; Wang GJ; Logan J; Gatley SJ; Pappas N
    Psychopharmacology (Berl); 1997 May; 131(1):71-8. PubMed ID: 9181638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate.
    Kim DI; Deutsch HM; Ye X; Schweri MM
    J Med Chem; 2007 May; 50(11):2718-31. PubMed ID: 17489581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs.
    Deutsch HM; Shi Q; Gruszecka-Kowalik E; Schweri MM
    J Med Chem; 1996 Mar; 39(6):1201-9. PubMed ID: 8632426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.
    Froimowitz M; Gu Y; Dakin LA; Nagafuji PM; Kelley CJ; Parrish D; Deschamps JR; Janowsky A
    J Med Chem; 2007 Jan; 50(2):219-32. PubMed ID: 17228864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine.
    Gatley SJ; Ding YS; Volkow ND; Chen R; Sugano Y; Fowler JS
    Eur J Pharmacol; 1995 Aug; 281(2):141-9. PubMed ID: 7589201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical characterization and differentiation between threo- and erythro-4-fluoroethylphenidate.
    Sakamoto M; Suzuki T; Teraoka D; Tanaka K; Saeki Y; Kishimoto K; Nagashima M; Nakajima J; Suzuki J; Inomata A; Moriyasu T; Fukaya H
    Forensic Toxicol; 2023 Jul; 41(2):272-286. PubMed ID: 37097346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.